It's one of many changes Bayer CEO Bill Anderson has made. Still, the company's stock price this year has struggled.

dsm-firmenich provides an update on the global vitamin market including supply disruptions and vitamin pricing changes ...

"They're negotiating over budgets for Q4 next year. They don't even know ... The company has also grappled with legal battles over Roundup, a herbicide produced by Monsanto, which Bayer purchased ...

The Q4 2022 quarter saw a growth in revenues of 14% year-to-year ... lot of negative attention due to lawsuits regarding the cancer risk of Monsanto’s legacy herbicide RoundUp. The company has put ...

Consolidated Operating Income: Increased by 15% in Q4 fiscal '24 compared to Q4 fiscal '23. Consolidated Net Sales: Improved by 8% in Q4 fiscal '24 compared to Q4 fiscal '23. Consolidated Net ...

GDP for Q4 is projected to rise 2.1% (real annualized rate), based on the median estimate. The recent stability in the median estimate at this late date for Q4 analysis offers a degree of ...

Bayer has been plagued by a number of cases tied to the herbicide since its $63 billion acquisition of Monsanto in 2018. The Australian court issued a 322-page ruling saying that the weight of ...

Caesars Entertainment announced it will release its Q4 results on Feb. 25 at 5 PM ET. Ahead of the reveal, J.P Morgan analyst Joseph Greff disclosed he's lowering his Q4 prediction from $499 ...